In the relentless race to bring life-saving drugs to market, every second counts. Yet, despite the urgency, many pharmaceutical companies find themselves ensnared in a complex web of regulatory hurdles, costly failures, and lengthy development timeline…
In the high-stakes world of pharmaceutical pricing, recent legislative shifts are sending shockwaves through the industry—and the ripple effects are just beginning to be felt.
The IRA Price Reset: A Game-Changer or Just the Beginning?
The Inflation Red…
The IRA Price Reset: What It Actually Does to Pharma Pricing — and What Comes Next Read Post »
The Patent Wall Crumbles: How Secondary Abandonment Is Reshaping the Future of Drug Innovation
In the high-stakes world of pharmaceutical innovation, the relentless pursuit of extending patent exclusivity has long been a strategic game. For decades, &q…
When the Patent Wall Crumbles: Secondary Abandonment and the Death of Drug Evergreening Read Post »
In the high-stakes world of pharmaceuticals, innovation alone isn’t enough. The real game-changer lies in how companies identify, secure, and leverage patent licensing opportunities to stay ahead of the curve. Yet, many organizations struggle to naviga…
The Strategic Playbook for Identifying and Securing Drug Patent Licensing Opportunities Read Post »
In the relentless race to develop groundbreaking new medicines, the pharmaceutical industry often overlooks a powerful, underutilized strategy: drug repurposing. As highlighted in the recent Drug Patent Watch blog post, “No Patents, No Problem? The Unt…
No Patents, No Problem: The Untapped Power of Drug Repurposing Read Post »
In the high-stakes world of pharmaceutical innovation, the race to bring a new drug to market is only part of the story. Once a blockbuster drug hits the shelves, the real battle begins—defending market share against a flood of generic competitors eage…
Beyond the API: Mapping the Secondary Patent Thicket to Forecast Generic Entry Read Post »
In the fiercely competitive world of specialty pharmacy, margins are razor-thin, and every dollar counts. But what if there was a way to double your margins—immediately—just by understanding a critical industry shift?
The Launch of Generics: A Double-…
Double Your Specialty Pharmacy Margins the Day Generics Launch Read Post »
In the high-stakes world of pharmaceuticals, blockbuster drugs are more than just revenue generators—they’re strategic assets that can define a company’s future. Yet, with the looming threat of patent challenges, generic competitors, and evolving regul…
Defend Your Blockbuster Drug. Here’s the Playbook. Read Post »
ð¨ The Truth About Drug Patents and Stock Success: Overnight Millionaires or Decades-long Marathon? ð¨
In the high-stakes world of biotech and pharmaceuticals, the narrative often goes like this: secure a patent, and overnight, your company transfo…
In the high-stakes world of pharmaceutical innovation, the race to develop the next blockbuster drug is relentless. Yet, lurking beneath the surface of patent filings and R&D pipelines lies an often-overlooked goldmine: abandoned drug patents and u…
Get new actionable insights and updates from BiotechBlog
